HYI: A Protein Involved in Pyruvate Metabolism and Potential Drug Target Or Biomarker

Target Name: HYI

NCBI ID: G81888

Content of Review Report on HYI Target / Biomarker

HYI

HYI: A Protein Involved in Pyruvate Metabolism and Potential Drug Target Or Biomarker

HYI (Putative hydroxypyruvate isomerase) is a protein that is expressed in various cell types, including neurons, muscle cells, and liver cells. It is involved in the metabolism of pyruvate, a crucial amino acid that is converted to acetyl-CoA, a key intermediate in the citric acid cycle.

HYI is a key enzyme in the citric acid cycle, which is a process that generates energy from the food we eat. In the citric acid cycle, pyruvate is converted to acetyl-CoA, which then enters the citric acid cycle's final stage, where it is converted to carbon dioxide and water.

HYI is a critical enzyme in the citric acid cycle, and it is involved in the production of the citric acid cycle's final product, carbon dioxide. It is also involved in the metabolism of other molecules, including amino acids, nucleotides, and lipids.

Research has suggested that HYI may be a drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular disease.

One potential mechanism by which HYI may be targeted by drugs is by inhibiting its activity. This could be done through a variety of methods, including inhibiting the activity of the enzyme using small molecules or interfering with its structure.

Another potential mechanism by which HYI may be used as a biomarker is by using it as a target for diagnostic tests. For example, researchers may use HYI as a marker to track the progression of neurodegenerative diseases, such as Alzheimer's disease.

Research has also suggested that HYI may be involved in the development of certain diseases, such as cancer. For example, studies have suggested that HYI may be involved in the development of colon cancer.

Overall, HYI is a protein that is involved in the metabolism of pyruvate, a crucial amino acid. It is also involved in the production of the citric acid cycle's final product and may be a potential drug target or biomarker for various diseases. Further research is needed to fully understand its role in the body and its potential as a therapeutic target.

Protein Name: Hydroxypyruvate Isomerase (putative)

Functions: Catalyzes the reversible isomerization between hydroxypyruvate and 2-hydroxy-3-oxopropanoate (also termed tartronate semialdehyde)

The "HYI Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HYI comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets